Modulation of vascular endothelial cell senescence by integrin ß4

Journal of Cellular Physiology

Volumn 225, Issue 3, 2010, Pages 673-681

  Sun, ChunHui ^a,b   Liu, Xia ^a,b   Qi, Lei ^a,b   Xu, JiPing ^c   Zhao, Jing ^a,b   Zhang, Yun ^b   Zhang, ShangLi ^a,b   Miao, JunYing ^a,b  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

^c THE SECOND HOSPITAL OF SHANDONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; ALPHA6 INTEGRIN; BETA ACTIN; BETA4 INTEGRIN; CAVEOLIN 1; CD31 ANTIGEN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; INTERLEUKIN 8; NITRIC OXIDE; ONCOPROTEIN; PROTEIN H RAS; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG; APOLIPOPROTEIN E; CAV1 PROTEIN, HUMAN; IL8 PROTEIN, HUMAN; NOS3 PROTEIN, HUMAN; RAS PROTEIN;

AGING; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; CYTOKINE RELEASE; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MITOCHONDRIAL MEMBRANE POTENTIAL; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SENESCENCE; SIGNAL TRANSDUCTION; THORACIC AORTA; VASCULAR DISEASE; VASCULAR ENDOTHELIUM; AGE; ANIMAL; C57BL MOUSE; CELL AGING; CELL CULTURE; DISEASE MODEL; GENETICS; METABOLISM; MOUSE MUTANT; PATHOLOGY; RNA INTERFERENCE;

AGE FACTORS; ANIMALS; AORTA, THORACIC; APOLIPOPROTEINS E; ATHEROSCLEROSIS; CAVEOLIN 1; CELL AGING; CELLS, CULTURED; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; HUMANS; INTEGRIN ALPHA6; INTEGRIN BETA4; INTERLEUKIN-8; MALE; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; RAS PROTEINS; RNA INTERFERENCE; TRANSCRIPTION FACTOR AP-1;

EID: 77957733736     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22262     Document Type: Article

References (80)

1. Anderson RG. 1993. Caveolae: where incoming and outgoing messengers meet. Proc Natl Acad Sci USA 90: 10909-10913.
2. Babcock GF. 1999. Quantitation of phagocytosis by confocal microscopy. Methods Enzymol 307: 319-328.
3. Behrendt D, Ganz P. 2002. Endothelial function. From vascular biology to clinical applications. Am J Cardiol 90: 40L-48L.
4. Birnbaum RY, Landau D, Elbedour K, Ofir R, Birk OS, Carmi R. 2008. Deletion of the first pair of fibronectin type III repeats of the integrin beta-4 gene is associated with epidermolysis bullosa, pyloric atresia and aplasia cutis congenita in the original Carmi syndrome patients. Am J Med Genet A 146A: 1063-1066.
5. Bode-Boger SM, Scalera F, Martens-Lobenhoffer J. 2005. Asymmetric dimethylarginine (ADMA) accelerates cell senescence. Vasc Med 10: S65-S71.
6. Boisvert WA, Santiago R, Curtiss LK, Terkeltaub RA. 1998. A leukocyte homologue of the IL-8 receptor CXCR-2 mediates the accumulation of macrophages in atherosclerotic lesions of LDL receptor-deficient mice. J Clin Invest 101: 353-363.
7. Borradori L, Sonnenberg A. 1999. Structure and function of hemidesmosomes: more than simple adhesion complexes B 1999. J Invest Dermatol 112: 411-418.
8. Burton DG, Giles PJ, Sheerin AN, Smith SK, Lawton JJ, Ostler EL, Rhys-Williams W, Kipling D, Faragher RG. 2009. Microarray analysis of senescent vascular smooth muscle cells: a link to atherosclerosis and vascular calcification. Exp Gerontol 44: 659-665.
9. Castro ME, Ferrer I, Cascon A, Guijarro MV, Lleonart M, Cajal S, Leal JF, Robledo M, Carnero A. 2008. PPP1CA contributes to the senescence program induced by oncogenic Ras. Carcinogenesis 29: 491-499.
10. Cho KA, Ryu SJ, Park JS, Jang IS, Ahn JS, Kim KT, Park SC. 2003. Senescent phenotype can be reversed by reduction of caveolin status. J Biol Chem 278: 27789-27795.
11. Cho KA, Ryu SJ, Oh YS, Park JH, Lee JW, Kim HP, Kim KT, Jang IS, Park SC. 2004. Morphological adjustment of senescent cells by modulating caveolin-1 status. J Biol Chem 279: 42270-42278.
12. Coppe JP, Kauser K, Campisi J, Beausejour CM. 2006. Secretion of vascular endothelial growth factor by primary human fibroblasts at senescence. J Biol Chem 281: 29568-29574.
13. Dasari A, Bartholomew JN, Volonte D, Galbiati F. 2006. Oxidative stress induces premature senescence by stimulating caveolin-1 gene transcription through p38 mitogen-activated protein kinase/Sp1-mediated activation of two GC-rich promoter elements. Cancer Res 66: 10805-10814.
14. de Pereda JM, Lillo MP, Sonnenberg A. 2009. Structural basis of the interaction between integrin alpha6beta4 and plectin at the hemidesmosomes. EMBO J 28: 1180-1190.
15. Dierick JF, Eliaers F, Remacle J, Raes M, Fey SJ, Larsen PM, Toussaint O. 2002. Stress-induced premature senescence and replicative senescence are different phenotypes, proteomic evidence. Biochem Pharmacol 64: 1011-1017.
16. Du AY, Zhao BX, Yin DL, Zhang SL, Miao JY. 2005. Discovery of a novel small molecule, 1-ethoxy-3-(3, 4-methylenedioxyphenyl)-2-propanol, that induces apoptosis in A549 human lung cancer cells. Bioorg Med Chem 13: 4176-4183.
17. Echarri A, Muriel O, Del Pozo MA. 2007. Intracellular trafficking of raft/caveolae domains: insights from integrin signaling. Semin Cell Dev Biol 18: 627-637.
18. Feron O, Dessy C, Desager JP, Balligand JL. 2001. Hydroxy-methylglutaryl-coenzyme A reductase inhibition promotes endothelial nitric oxide synthase activation through a decrease in caveolin abundance. Circulation 103: 113-118.
19. Gaus K, Le LS, Balasubramanian N, Schwartz MA. 2006. Integrin-mediated adhesion regulates membrane order. J Cell Biol 174: 725-734.
20. Guo W, Pylayeva Y, Pepe A, Yoshioka T, Muller WJ, Inghirami G, Giancotti FG. 2006. Beta 4 integrin amplifies ErbB2 signaling to promote mammary tumorigenesis G2006. Cell 126: 489-502.
21. Haendeler J, Hoffmann J, Diehl JF, Vasa M, Spyridopoulos I, Zeiher AM, Dimmeler S. 2004. Antioxidants inhibit nuclear export of telomerase reverse transcriptase and delay replicative senescence of endothelial cells. Circ Res 94: 768-775.
22. Hampel B, Fortschegger K, Ressler S, Chang MW, Unterluggauer H, Breitwieser A, Sommergruber W, Fitzky B, Lepperdinger G, Jansen-Durr P, Voglauer R, Grillari J. 2006. Increased expression of extracellular proteins as a hallmark of human endothelial cell in vitro senescence. Exp Gerontol 41: 474-481.
23. Hayashi T, Matsui-Hirai H, Miyazaki-Akita A, Fukatsu A, Funami J, Ding QF, Kamalanathan S, Hattori Y, Ignarro LJ, Iguchi A. 2006. Endothelial cellular senescence is inhibited by nitric oxide: implications in atherosclerosis associated with menopause and diabetes H2006. Proc Natl Acad Sci USA 103: 17018-17023.
24. Henriksen PA, Hitt M, Xing Z, Wang J, Haslett C, Riemersma RA, Webb DJ, Kotelevtsev YV, Sallenave JM. 2004. Adenoviral gene delivery of elafin and secretory leukocyte protease inhibitor attenuates NF-kappa B-dependent inflammatory responses of human endothelial cells and macrophages to atherogenic stimuli. J Immunol 172: 4535-4544.
25. Herbein G, Varin A, Fulop T. 2006. NF-kappaB, AP-1, zinc-deficiency and aging H2006. Biogerontology 7: 409-419.
26. Hutter E, Unterluggauer H, Uberall F, Schramek H, Jansen-Durr P. 2002. Replicative senescence of human fibroblasts: the role of Ras-dependent signaling and oxidative stress. Exp Gerontol 37: 1165-1174.
27. Hutter E, Skovbro M, Lener B, Prats C, Rabol R, Dela F, Jansen-Durr P. 2007. Oxidative stress and mitochondrial impairment can be separated from lipofuscin accumulation in aged human skeletal muscle. Aging Cell 6: 245-256.
28. Iacovacci S, Cicuzza S, Odorisio T, Silvestri E, Kayserili H, Zambruno G, Puddu P, D'Alessio M. 2003. Novel and recurrent mutations in the integrin beta 4 subunit gene causing lethal junctional epidermolysis bullosa with pyloric atresia. Exp Dermatol 12: 716-720.
29. Ignarro LJ, Buga GM, Wei LH, Bauer PM, Wu G, del SP. 2001. Role of the arginine-nitric oxide pathway in the regulation of vascular smooth muscle cell proliferation. Proc Natl Acad Sci USA 98: 4202-4208.
30. Inomata M, Shimada Y, Hayashi M, Kondo H, Ohno-Iwashita Y. 2006. Detachment-associated changes in lipid rafts of senescent human fibroblasts. Biochem Biophys Res Commun 343: 489-495.
31. Jaffe EA, Nachman RL, Becker CG, Minick CR. 1973. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 52: 2745-2756.
32. Jones JC, Hopkinson SB, Goldfinger LE. 1998. Structure and assembly of hemidesmosomes. Bioessays 20: 488-494.
33. Kawabe JI, Grant BS, Yamamoto M, Schwencke C, Okumura S, Ishikawa Y. 2001. Changes in caveolin subtype protein expression in aging rat organs. Mol Cell Endocrinol 176: 91-95.
34. Kim HJ, Jung KJ, Yu BP, Cho CG, Choi JS, Chung HY. 2002. Modulation of redox-sensitive transcription factors by calorie restriction during aging. Mech Ageing Dev 123: 1589-1595.
35. Kim KS, Seu YB, Baek SH, Kim MJ, Kim KJ, Kim JH, Kim JR. 2007. Induction of cellular senescence by insulin-like growth factor binding protein-5 through a p53-dependent mechanism. Mol Biol Cell 18: 4543-4552.
36. Konishi Y, Stegmuller J, Matsuda T, Bonni S, Bonni A. 2004. Cdh1-APC controls axonal growth and patterning in the mammalian brain. Science 303: 1026-1030.
37. Krejci P, Prochazkova J, Smutny J, Chlebova K, Lin P, Aklian A, Bryja V, Kozubik A, Wilcox WR. 2010. FGFR3 signaling induces a reversible senescence phenotype in chondrocytes similar to oncogene-induced premature senescence. Bone. [Epub ahead of print].
38. Linge A, Weinhold K, Blasche R, Kasper M, Barth K. 2007. Downregulation of caveolin-1 affects bleomycin-induced growth arrest and cellular senescence in A549 cells. Int J Biochem Cell Biol 39: 1964-1974.
39. Liu X, Yin D, Zhang Y, Zhao J, Zhang S, Miao J. 2007. Vascular endothelial cell senescence mediated by integrin beta4 in vitro L2007. FEBS Lett 581: 5337-5342.
40. Lv X, Su L, Yin D, Sun C, Zhao J, Zhang S, Miao J. 2008. Knockdown of integrin beta4 in primary cultured mouse neurons blocks survival and induces apoptosis by elevating NADPH oxidase activity and reactive oxygen species level. Int J Biochem Cell Biol 40: 689-699.
41. Madamanchi NR, Runge MS. 2007. Mitochondrial dysfunction in atherosclerosis. Circ Res 100: 460-473.
42. Mainiero F, Pepe A, Wary KK, Spinardi L, Mohammadi M, Schlessinger J, Giancotti FG. 1995. Signal transduction by the alpha 6 beta 4 integrin: distinct beta 4 subunit sites mediate recruitment of Shc/Grb2 and association with the cytoskeleton of hemidesmosomes. EMBO J 14: 4470-4481.
43. Mainiero F, Pepe A, Yeon M, Ren Y, Giancotti FG. 1996. The intracellular functions of alpha6beta4 integrin are regulated by EGF. J Cell Biol 134: 241-253.
44. Mainiero F, Murgia C, Wary KK, Curatola AM, Pepe A, Blumemberg M, Westwick JK, Der CJ, Giancotti FG. 1997. The coupling of alpha6beta4 integrin to Ras-MAP kinase pathways mediated by Shc controls keratinocyte proliferation. EMBO J 16: 2365-2375.
45. Matsushita H, Chang E, Glassford AJ, Cooke JP, Chiu CP, Tsao PS. 2001. eNOS activity is reduced in senescent human endothelial cells: preservation by hTERT immortalization. Circ Res 89: 793-798.
46. Miao JY, Araki S, Kaji K, Hayashi H. 1997. Integrin beta4 is involved in apoptotic signal transduction in endothelial cells. Biochem Biophys Res Commun 233: 182-186.
47. Micheloni A, De LN Tadini G, Zambruno G, D'Alessio M. 2004. Intracellular degradation of beta4 integrin in lethal junctional epidermolysis bullosa with pyloric atresia. Br J Dermatol 151: 796-802.
48. Min LJ, Mogi M, Iwai M, Horiuchi M. 2009. Signaling mechanisms of angiotensin II in regulating vascular senescence. Ageing Res Rev 8: 113-121.
49. Minamino T, Miyauchi H, Yoshida T, Ishida Y, Yoshida H, Komuro I. 2002. Endothelial cell senescence in human atherosclerosis: role of telomere in endothelial dysfunction. Circulation 105: 1541-1544.
50. Minamino T, Yoshida T, Tateno K, Miyauchi H, Zou Y, Toko H, Komuro I. 2003. Ras induces vascular smooth muscle cell senescence and inflammation in human atherosclerosis. Circulation 108: 2264-2269.
51. Moiseeva O, Bourdeau V, Roux A, Schenes-Simard X, Ferbeyre G. 2009. Mitochondrial dysfunction contributes to oncogene-induced senescence. Mol Cell Biol 29: 4495-4507.
52. Monaco C, Andreakos E, Kiriakidis S, Mauri C, Bicknell C, Foxwell B, Cheshire N, Paleolog E, Feldmann M. 2004. Canonical pathway of nuclear factor kappa B activation selectively regulates proinflammatory and prothrombotic responses in human atherosclerosis. Proc Natl Acad Sci USA 101: 5634-5639.
53. Murohara T, Witzenbichler B, Spyridopoulos I, Asahara T, Ding B, Sullivan A, Losordo DW, Isner JM. 1999. Role of endothelial nitric oxide synthase in endothelial cell migration. Arterioscler Thromb Vasc Biol 19: 1156-1161.
54. Nakashima Y, Plump AS, Raines EW, Breslow JL, Ross R. 1994. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler Thromb 14: 133-140.
55. Nikolopoulos SN, Blaikie P, Yoshioka T, Guo W, Giancotti FG. 2004. Integrin beta4 signaling promotes tumor angiogenesis. Cancer Cell 6: 471-483.
56. Nikolopoulos SN, Blaikie P, Yoshioka T, Guo W, Puri C, Tacchetti C, Giancotti FG. 2005. Targeted deletion of the integrin beta4 signaling domain suppresses laminin-5-dependent nuclear entry of mitogen-activated protein kinases and NF-kappaB, causing defects in epidermal growth and migration. Mol Cell Biol 25: 6090-6102.
57. Park WY, Park JS, Cho KA, Kim DI, Ko YG, Seo JS, Park SC. 2000. Up-regulation of caveolin attenuates epidermal growth factor signaling in senescent cells. J Biol Chem 275: 20847-20852.
58. Passos JF, von ZT. 2005. Mitochondria, telomeres and cell senescence. Exp Gerontol 40: 466-472.
59. Payne E, Bowles MR, Don A, Hancock JF, McMillan NA. 2001. Human papillomavirus type 6b virus-like particles are able to activate the Ras-MAP kinase pathway and induce cell proliferation. J Virol 75: 4150-4157.
60. Qiao M, Kisgati M, Cholewa JM, Zhu W, Smart EJ, Sulistio MS, Asmis R. 2007. Increased expression of glutathione reductase in macrophages decreases atherosclerotic lesion formation in low-density lipoprotein receptor-deficient mice. Arterioscler Thromb Vasc Biol 27: 1375-1382.
61. Raymond K, Kreft M, Janssen H, Calafat J, Sonnenberg A. 2005. Keratinocytes display normal proliferation, survival and differentiation in conditional beta4-integrin knockout mice. J Cell Sci 118: 1045-1060.
62. Rittie L, Fisher GJ. 2002. UV-light-induced signal cascades and skin aging. Ageing Res Rev 1: 705-720.
63. Scalera F, Borlak J, Beckmann B, Martens-Lobenhoffer J, Thum T, Tager M, Bode-Boger SM. 2004. Endogenous nitric oxide synthesis inhibitor asymmetric dimethyl L-arginine accelerates endothelial cell senescence. Arterioscler Thromb Vasc Biol 24: 1816-1822.
64. Shi Q, Hubbard GB, Kushwaha RS, Rainwater D, Thomas CA, III, Leland MM, Vandeberg JL, Wang XL. 2007. Endothelial senescence after high-cholesterol, high-fat diet challenge in baboons. Am J Physiol Heart Circ Physiol 292: H2913-H2920.
65. Simonini A, Moscucci M, Muller DW, Bates ER, Pagani FD, Burdick MD, Strieter RM. 2000. IL-8 is an angiogenic factor in human coronary atherectomy tissue. Circulation 101: 1519-1526.
66. Song KS, Li S, Okamoto T, Quilliam LA, Sargiacomo M, Lisanti MP. 1996. Co-purification and direct interaction of Ras with caveolin, an integral membrane protein of caveolae microdomains. Detergent-free purification of caveolae microdomains. J Biol Chem 271: 9690-9697.
67. Spyridopoulos I, Isner JM, Losordo DW. 2002. Oncogenic ras induces premature senescence in endothelial cells: role of p21(Cip1/Waf1). Basic Res Cardiol 97: 117-124.
68. Sun C, Wang N, Huang J, Xin J, Peng F, Ren Y, Zhang S, Miao J. 2009. Inhibition of phosphatidylcholine-specific phospholipase C prevents bone marrow stromal cell senescence in vitro. J Cell Biochem 108: 519-528.
69. Swarbrick A, Roy E, Allen T, Bishop JM. 2008. Id1 cooperates with oncogenic Ras to induce metastatic mammary carcinoma by subversion of the cellular senescence response. Proc Natl Acad Sci USA 105: 5402-5407.
70. Takaoka AS, Yamada T, Gotoh M, Kanai Y, Imai K, Hirohashi S. 1998. Cloning and characterization of the human beta4-integrin gene promoter and enhancers T 1998. J Biol Chem 273: 33848-33855.
71. Thomas SR, Witting PK, Drummond GR. 2008. Redox control of endothelial function and dysfunction: molecular mechanisms and therapeutic opportunities. Antioxid Redox Signal 10: 1713-1765.
72. Trusolino L, Bertotti A, Comoglio PM. 2001. A signaling adapter function for alpha6beta4 integrin in the control of HGF-dependent invasive growth. Cell 107: 643-654.
73. Volonte D, Zhang K, Lisanti MP, Galbiati F. 2002. Expression of caveolin-1 induces premature cellular senescence in primary cultures of murine fibroblasts. Mol Biol Cell 13: 2502-2517.
74. Wang W, Chen JX, Liao R, Deng Q, Zhou JJ, Huang S, Sun P. 2002. Sequential activation of the MEK-extracellular signal-regulated kinase and MKK3/6-p38 mitogen-activated protein kinase pathways mediates oncogenic ras-induced premature senescence. Mol Cell Biol 22: 3389-3403.
75. Wang W, Liu X, Zhang Y, Zhao J, Zhao B, Zhang S, Miao J. 2007. Both senescence and apoptosis induced by deprivation of growth factors were inhibited by a novel butyrolactone derivative through depressing integrin beta4 in vascular endothelial cells. Endothelium 14: 325-332.
76. Yao SK, Ober JC, Ferguson JJ, Anderson HV, Maraganore J, Buja LM, Willerson JT. 1992. Combination of inhibition of thrombin and blockade of thromboxane A2 synthetase and receptors enhances thrombolysis and delays reocclusion in canine coronary arteries. Circulation 86: 1993-1999.
77. Zeiher AM, Fisslthaler B, Schray-Utz B, Busse R. 1995. Nitric oxide modulates the expression of monocyte chemoattractant protein 1 in cultured human endothelial cells. Circ Res 76: 980-986.
78. Zhao Q, Araki S, Zhang S, Miao J. 2004. Rattlesnake venom induces apoptosis by stimulating PC-PLC and upregulating the expression of integrin beta4, P53 in vascular endothelial cells. Toxicon 44: 161-168.
79. Zorov DB, Juhaszova M, Sollott SJ. 2006. Mitochondrial ROS-induced ROS release: an update and review. Biochim Biophys Acta 1757: 509-517.
80. Zulli A, Buxton BF, Black MJ, Ming Z, Cameron A, Hare DL. 2006. The immunoquantification of caveolin-1 and eNOS in human and rabbit diseased blood vessels Z2006. J Histochem Cytochem 54: 151-159.